[1]
“A NEW GENE THERAPY PARADIGM IN VIVO CRISPR ENGINEERING OF HEMATOPOIETIC NICHES FOR CANCER IMMUNOTHERAPY”, FMHR, vol. 4, no. 6, pp. 1756–1802, Jun. 2026, Accessed: Jun. 26, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/3230